# Clinical Trial to Evaluate the Efficacy and Safety of LEVI-04 in Patients With Osteoarthritis of the Knee

> **NCT05618782** · PHASE2 · COMPLETED · sponsor: **Levicept** · enrollment: 518 (actual)

## Conditions studied

- Pain
- Osteo Arthritis Knee
- Knee Osteoarthritis
- Arthritis
- Joint Diseases
- Musculoskeletal Diseases
- Rheumatic Diseases

## Interventions

- **DRUG:** LEVI-04
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05618782
- **Lead sponsor:** Levicept
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-19
- **Primary completion:** 2024-05-20
- **Final completion:** 2024-05-20
- **Target enrollment:** 518 (ACTUAL)
- **Last updated:** 2025-11-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05618782

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05618782, "Clinical Trial to Evaluate the Efficacy and Safety of LEVI-04 in Patients With Osteoarthritis of the Knee". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05618782. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*